ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of Erlotinib in Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00497224
Recruitment Status : Completed
First Posted : July 6, 2007
Last Update Posted : July 9, 2013
Sponsor:
Collaborator:
OSI Pharmaceuticals
Information provided by (Responsible Party):
University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : June 2013